
Sinxiga 10mg Tablet
Marketer
Sinsan Pharmaceuticals
Salt Composition
Dapagliflozin (10mg)
Overview Sinxiga 10mg Tablet
Dapagliflozin 10mg tablets are prescribed either independently or alongside other medications to manage type 2 diabetes. They effectively regulate elevated blood glucose, mitigating the risk of severe diabetic complications and potentially preventing cardiovascular disease. This medication may be administered with or without food, consistently at the same time each day, as determined by your physician. Discontinuing treatment without consulting your doctor can lead to heightened blood sugar and potentially serious consequences such as renal impairment and vision loss. This drug forms one element of a comprehensive diabetes management plan, encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Commonly reported side effects include vaginal yeast infections, upper respiratory tract inflammation, and urinary tract infections. Fluid loss is a potential adverse effect; adequate hydration is crucial. Practicing good hygiene can reduce the risk of genital fungal infections. Prior to commencing treatment, discuss any existing kidney or liver conditions, urinary tract infections, or diuretic use with your doctor. Pregnant or lactating individuals should seek medical advice before using this medication. Excessive alcohol consumption should be avoided, as it may heighten the likelihood of experiencing adverse reactions. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Sinxiga 10mg Tablet
There is no text provided to rephrase.
Uses of Sinxiga 10mg Tablet
Managing type 2 diabetes
Major Benefits of Sinxiga 10mg Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sinxiga 10mg Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Sinxiga 10mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Sinxiga 10mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sinxiga 10mg tablets can be consumed with or without food, though consistent daily timing is recommended.
How Sinxiga 10mg Tablet works:
Dapagliflozin 10mg tablets are used to manage diabetes. Their mechanism involves facilitating the excretion of surplus glucose via the kidneys.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Sinxiga 10mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Sinxiga 10mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Sinxiga 10mg tablets while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely avoid Sinxiga 10mg tablets due to potential safety concerns. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
For individuals with hepatic impairment, Sinxiga 10mg tablets are considered safe for administration. Dosage modification of Sinxiga 10mg tablets is unnecessary.
What if you forget to take Sinxiga 10mg Tablet :
Should you forget a Sinxiga 10mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sinxiga 10mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
